Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer.

"Declarations Ethical approval and consent to participateOur study was approved by ethic committee of Affiliated Hospital of Inner Mongolia Medical University and Nanfang Hospital of Southern Medical University, in accordance with The Helsinki Declaration. All participants have provided the informed consents. Consent for publicationNot applicable. Competing interestsThe authors declare that there is no competing interest regarding the publication of this paper. Competing interests The authors declare that there is no competing interest regarding the publication of this paper."

"Funding This study was supported by Autonomous region health science and technology plan projects of Health Commission of Inner Mongolia (2022) (202201289) and Million-dollar joint projects of Inner Mongolia Medical University (YKD2021LH035)."